Marks Gilbert Lynn bought ANTX
July 10, 2025 · Form 4 insider transaction
Marks Gilbert Lynn bought 11,875 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,875
Price
$0.00
Total value
N/A
InsiderMarks Gilbert Lynn
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 10, 2025
Filing dateJuly 11, 2025
Shares owned after53,382
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.